| |
 |
Frederic Bedin Patents |
|
Inventor: Bedin; Frederic
Address: Lyons, FR
No. of patents: 9
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 6582703 |
Isolated nucleotide sequences associated with multiple sclerosis or rheumatoid arthritis and a p |
June 24, 2003 |
| The invention provides viral material and nucleotide fragments associated with multiple sclerosis and/or rheumatoid arthritis for use in methods of diagnosis, prophylaxis, and therapy. |
| 6579526 |
Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prop |
June 17, 2003 |
| Viral material, in the isolated or purified state, in which the genome comprises a nucleotide sequence chosen from the group including sequences SEQ ID NO:46, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53 and SEQ ID NO:56, their complementary sequences and their equivalent sequences, in p |
| 6342383 |
Cell lines and viral isolates associated with multiple sclerosis |
January 29, 2002 |
| Composition comprising two pathogenic and/or infective agents associated with multiple sclerosis, namely a first agent which consists of a human virus possessing reverse transcriptase activity and related to a family of endogenous retroviral elements, or a variant of said virus, and a se |
| 6184025 |
Viral isolates associated with multiple sclerosis |
February 6, 2001 |
| Composition comprising two pathogenic and/or infective agents associated with multiple sclerosis, namely a first agent which consists of a human virus possessing reverse transcriptase activity and related to a family of endogenous retroviral elements, or a variant of said virus, and a se |
| 6001987 |
Isolated nucleotide sequences associated with Multiple sclerosis |
December 14, 1999 |
| Viral material, in the isolated or purified state, in which the genome comprises a nucleotide sequence chosen from the group including sequences SEQ ID NO:46, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53 and SEQ ID NO:56, their complementary sequences and their equivalent sequences, in p |
| 5962217 |
MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, and bi |
October 5, 1999 |
| Composition including two pathogenic and/or infective agents associated with multiple sclerosis, namely a first agent which consists of a human virus possessing reverse transcriptase activity and related to a family of endogenous retroviral elements, or a variant of the virus, and a seco |
| 5871996 |
Retrovirus agents MSRV1 and MSRV2 associated with multiple sclerosis |
February 16, 1999 |
| Composition including two pathogenic and/or infective agents associated with multiple sclerosis, namely a first agent which consists of a human virus possessing reverse transcriptase activity and related to a family of endogenous retroviral elements, or a variant of the virus, and a seco |
| 5871745 |
Multiple sclerosis related virus |
February 16, 1999 |
| Composition including two pathogenic and/or infective agents associated with multiple sclerosis, namely a first agent which consists of a human virus possessing reverse transcriptase activity and related to a family of endogenous retroviral elements, or a variant of the virus, and a seco |
| 5800980 |
Detection of MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple scle |
September 1, 1998 |
| Composition including two pathogenic and/or infective agents associated with multiple sclerosis, namely a first agent which consists of a human virus possessing reverse transcriptase activity and related to a family of endogenous retroviral elements, or a variant of the virus, and a seco |
|
|
|
